CryoLife Inc.

23.70-0.0400-0.17%Vol 70.83K1Y Perf 28.56%
Sep 23rd, 2021 13:44 DELAYED
BID23.68 ASK23.72
Open23.78 Previous Close23.74
Pre-Market- After-Market-
 - -%  - -
Target Price
34.19 
Analyst Rating
Moderate Buy 1.67
Potential %
44.44 
Finscreener Ranking
★★★     49.04
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.34
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     44.55
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
45.11 
Earnings Rating
Strong Buy
Market Cap931.55M 
Earnings Date
3rd Nov 2021
Alpha-0.01 Standard Deviation0.11
Beta1.52 

Today's Price Range

23.4123.82

52W Range

16.6032.34

5 Year PE Ratio Range

-259.50684.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-3.61%
1 Month
-8.41%
3 Months
-19.44%
6 Months
5.65%
1 Year
28.56%
3 Years
-31.39%
5 Years
30.87%
10 Years
447.90%

TickerPriceChg.Chg.%
CRY23.70-0.0400-0.17
AAPL146.921.07000.73
GOOG2 842.2123.44000.83
MSFT300.121.54000.52
XOM57.041.83003.31
WFC48.030.95002.02
JNJ165.521.59000.97
FB346.623.41000.99
GE103.775.23005.31
JPM161.515.60003.59
Financial StrengthValueIndustryS&P 500US Markets
1.80
4.00
0.54
1.19
0.40
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
66.40
2.70
10.90
2.00
-4.07
RevenueValueIndustryS&P 500US Markets
280.26M
7.13
2.91
10.13
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.05-0.06-20.00
Q01 2021-0.11-0.0827.27
Q04 2020-0.020.201.10K
Q03 2020-0.010.131.40K
Q02 2020-0.03-0.0233.33
Q01 20200.02-0.08-500.00
Q04 20190.070.1042.86
Q03 20190.040.0650.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.05266.67Positive
12/2021 QR0.0775.00Positive
12/2021 FY-0.0564.29Positive
12/2022 FY0.26116.67Positive
Next Report Date3rd Nov 2021
Estimated EPS Next Report0.05
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume70.83K
Shares Outstanding39.31M
Shares Float31.07M
Trades Count1.42K
Dollar Volume8.16M
Avg. Volume178.07K
Avg. Weekly Volume235.70K
Avg. Monthly Volume152.20K
Avg. Quarterly Volume126.26K

CryoLife Inc. (NYSE: CRY) stock closed at 23.74 per share at the end of the most recent trading day (a 0.72% change compared to the prior day closing price) with a volume of 93.29K shares and market capitalization of 931.55M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1200 people. CryoLife Inc. CEO is James Patrick Mackin.

The one-year performance of CryoLife Inc. stock is 28.56%, while year-to-date (YTD) performance is 0.55%. CRY stock has a five-year performance of 30.87%. Its 52-week range is between 16.6 and 32.34, which gives CRY stock a 52-week price range ratio of 45.11%

CryoLife Inc. currently has a PE ratio of -77.20, a price-to-book (PB) ratio of 3.12, a price-to-sale (PS) ratio of 3.22, a price to cashflow ratio of 72.50, a PEG ratio of 2.32, a ROA of -1.50%, a ROC of -0.08% and a ROE of -3.76%. The company’s profit margin is -4.07%, its EBITDA margin is 10.90%, and its revenue ttm is $280.26 Million , which makes it $7.13 revenue per share.

Of the last four earnings reports from CryoLife Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.05 for the next earnings report. CryoLife Inc.’s next earnings report date is 03rd Nov 2021.

The consensus rating of Wall Street analysts for CryoLife Inc. is Moderate Buy (1.67), with a target price of $34.19, which is +44.44% compared to the current price. The earnings rating for CryoLife Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CryoLife Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CryoLife Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 8.10, ATR14 : 0.81, CCI20 : -108.65, Chaikin Money Flow : -0.17, MACD : -0.66, Money Flow Index : 31.10, ROC : -7.88, RSI : 37.18, STOCH (14,3) : 24.76, STOCH RSI : 0.74, UO : 43.38, Williams %R : -75.24), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CryoLife Inc. in the last 12-months were: Amy D. Horton (Option Excercise at a value of $225 661), Amy D. Horton (Sold 33 902 shares of value $894 724 ), David Ashley Lee (Option Excercise at a value of $240 960), David Ashley Lee (Sold 50 708 shares of value $1 404 578 ), Dennis B Maier (Option Excercise at a value of $214 293), Dennis B Maier (Sold 15 616 shares of value $395 947 ), James Patrick Mackin (Option Excercise at a value of $465 572), James Patrick Mackin (Sold 45 734 shares of value $1 280 552 ), Jean F. Holloway (Option Excercise at a value of $135 537), Jean F. Holloway (Sold 31 184 shares of value $914 887 ), John E. Davis (Option Excercise at a value of $141 748), John E. Davis (Sold 12 739 shares of value $377 880 ), Ronald D. Mccall (Sold 16 088 shares of value $417 222 ), Scott B. Capps (Option Excercise at a value of $99 700), Scott B. Capps (Sold 8 366 shares of value $178 553 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (50.00 %)
3 (50.00 %)
Moderate Buy
2 (33.33 %)
2 (33.33 %)
2 (33.33 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

CryoLife Inc.

Cryolife Inc is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. The company has two reportable segments namely Medical devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue, On-X products, JOTEC products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular tissues. It generates a majority of its revenue from the Medical Devices segment. Geographically, the company generates a majority of its revenue from the United States.

CEO: James Patrick Mackin

Telephone: +1 770 419-3355

Address: 1655 Roberts Boulevard North West, Kennesaw 30144, GA, US

Number of employees: 1 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

59%41%

News

Stocktwits